Advertisement
Financing › Details
Science 37–SEVERAL: investment, 201610 financing round Series B $31m led by Redmile Group + incl Lux Capital + dRx Capital + SGBV
Period | 2016-10-18 | |
Money taker | Science 37 Inc. | |
Money source | SEVERAL | |
Product | clinical research software | |
Product 2 | venture capital | |
Record changed: 2018-04-01 |
Advertisement
More documents for Science 37 Inc.
- [1] Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies". Ingelheim & Playa Vista, CA....
- [2] Science 37 Inc.. (5/3/18). "Press Release: Science 37 Partners with UCB to Fundamentally Change the Clinical Trial Ecosystem, Focusing on More Patient-Friendly, Technology-Enabled Trials at Home". Playa Vista, CA....
- [3] Novartis AG. (3/7/18). "Press Release: Novartis Expands Alliance with Science 37 to Advance Virtual Clinical Trials Program". Basel....
- [4] Science 37 Inc.. (3/1/17). "Press Release: Science 37 and Sanofi Introduce a New Partnership". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top